{"id":534,"date":"2020-04-23T15:27:49","date_gmt":"2020-04-23T14:27:49","guid":{"rendered":"https:\/\/wp.modronebo.net\/ijs2\/?post_type=team&#038;p=534"},"modified":"2024-07-29T15:23:32","modified_gmt":"2024-07-29T13:23:32","slug":"prof-boris-rogelj","status":"publish","type":"team","link":"https:\/\/www-b3.ijs.si\/index.php\/rushmore_teams\/prof-boris-rogelj\/","title":{"rendered":"Prof. Boris Rogelj, PhD"},"content":{"rendered":"\n<p><strong>Research intersts<\/strong><br>Molecular basis of neurological disorders amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), Alzheimer&#8217;s disease (AD), Prader\u2014Willi syndrome (PWS) and others.<br>\u2022 Function and regulation of RNA-binding proteins in ALS and FTD.<br>\u2022 Nuclear transport of RNA and proteins.<br>\u2022 Cellular stress response.<br>\u2022 RNA and protein interactomes.<br>\u2022 Structure and function of noncanonical DNA and RNA.<br>\u2022 Role of ncRNAs in neurodegeneration.<br>\u2022 Genetics of ALS and FTD.<br>\u2022 RNA-RNA interactome of snoRNAs associated with PWS.<\/p>\n\n\n\n<p><strong>Major scientific achievements<\/strong><br>\u2022 Identified mutations in genes coding for TDP-43 and FUS in sporadic and familial ALS.<br>\u2022 Neuropathological characterization of TDP-43, FUS, optineurin and C9orf72 in ALS and\/or FTD.<br>\u2022 Characterized RNA binding properties and nuclear transport of TDP-43 and FUS.<br>\u2022 Showed that mutant FUS has propensity to form stress granules.<br>\u2022 Defined phosphorylation of 526Y of FUS as important for mislocalization.<br>\u2022 Shown that the sense strand DNA of C9orf72 can form G-quadruplexes, while the antisense strand can form i-motifs\/protonated hairpins.<br>\u2022 Characterized the proteins that bind to the sense strand of C9orf72 repeat RNA.<br>\u2022 Determined changes in microRNA associated with muscle atrophy in ALS.<br>\u2022 Lead of Slovenian section in international consortia for genetic characterization of ALS and FTD.<br>\u2022 Showed involvement of orphan snoRNAs in learning and memory.<\/p>\n\n\n\n<p><strong>Appointments:<\/strong><br>2019- Head of Department of Biotechnology &#8211; Jo\u017eef Stefan Institute, Ljubljana, Slovenia<br>2013- University teacher &#8211; Faculty of Chemistry and Chemical Technology, University of Ljubljana, Slovenia<br>2011- Research group leader \/ Scientific consultant &#8211; Biomedical Research Institute, Ljubljana, Slovenia<br>2011-2019 Scientific associate \/ Research group leader &#8211; Jo\u017eef Stefan Institute, Ljubljana, Slovenia<br>2007-2011 Senior research associate \/ status of lecturer &#8211; Dept. of Clinical Neuroscience, Institute of Psychiatry, King\u2019s College London, UK<br>2003-2007 Senior postdoctoral researcher &#8211; Dept. of Neuroscience, Institute of Psychiatry, King\u2019s College London, UK<br>2000-2003 Research fellow &#8211; Dept. of Anatomy and Developmental Biology and Wolfson Institute for Biomedical Research, University College London, UK<br>1999-2000 Postdoctoral researcher &#8211; Dept. of Biochemistry and Mol. Biology, Jo\u017eef Stefan Institute, Ljubljana, Slovenia<\/p>\n\n\n\n<p><strong>Major awards:<\/strong><br>\u2022 2019 Prestigious national Zois recognition for contribution to the development of science and research in the Republic of Slovenia in the field of molecular neurodegeneration.<br>\u2022 2017 Lapanje award from Slovenian Biochemical Society for exceptional scientific, educational and professional achievements in the field of Biochemical Sciences.<\/p>\n\n\n\n<p><strong>Current grants as PI:<\/strong><br>\u2022 Regulation of intracellular complexes formed by dipeptide repeats from C9ORF72 mutation. CRP-ICGEB, 2020-2022; \u20ac45,000.<br>\u2022 N3-0141 Nuclear transport defects in frontotemporal dementia. Lead Agency: Hungarian National Research, Development and Innovation Office \/ Slovenian Research Agency; 2020-2022; \u20ac109,275.<br>\u2022 J3-9263 Role of paraspeckle like nuclear bodies in pathogenesis of ALS and FTD. Slovenian Research Agency; 2018-2021; \u20ac300,000.<br>\u2022 J3-8201 Nuclear transport defects in neurodegenerative diseases. Slovenian Research Agency; 2017-2020; \u20ac300,000.<\/p>\n","protected":false},"featured_media":0,"template":"","team_cat":[23],"_links":{"self":[{"href":"https:\/\/www-b3.ijs.si\/index.php\/wp-json\/wp\/v2\/team\/534"}],"collection":[{"href":"https:\/\/www-b3.ijs.si\/index.php\/wp-json\/wp\/v2\/team"}],"about":[{"href":"https:\/\/www-b3.ijs.si\/index.php\/wp-json\/wp\/v2\/types\/team"}],"wp:attachment":[{"href":"https:\/\/www-b3.ijs.si\/index.php\/wp-json\/wp\/v2\/media?parent=534"}],"wp:term":[{"taxonomy":"team_cat","embeddable":true,"href":"https:\/\/www-b3.ijs.si\/index.php\/wp-json\/wp\/v2\/team_cat?post=534"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}